TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial.

A Poveda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.